Laura Pat Svetkey, MD

Professor of Medicine
Director of Clinical Research
Vice-chair for Faculty Development & Diversity in the Department of Medicine
Campus mail Duke Box 3487, Durham, NC 27710
Phone (919) 660-6626
Email address svetk001@mc.duke.edu

Laura P. Svetkey, MD MHS is Professor of Medicine, Director of the Duke Hypertension Center, Director of Clinical Research at the Sarah W. Stedman Nutrition and Metabolism Center, Vice Chair for Faculty Development and Diversity in the Department of Medicine. She is also the Director of Duke’s CTSA internal career development award program (KL2).She is a faculty member of the Duke Molecular Physiology Institute (DMPI) and the Cardiovascular Research Center (CVRC). She is co-Director of the Clinical and Translational Core of the Duke O’Brien Center for Kidney Research (DOCK).

Dr. Svetkey has over 30 years of experience in the investigation of hypertension, obesity, and related areas, conducting NIH-sponsored clinical research ranging from behavioral intervention trials to metabolomics and genetics, with a consistent focus on prevention, non-pharmacologic intervention, health disparities and minority health. Her research has affected national guidelines, having served on the 2013 national Hypertension Guideline Panel (JNC) and the Lifestyle Guideline Working Group. She is a member of the Association of American Physicians (AAP).

Dr. Svetkey is Vice Chair for Faculty Development and Diversity in the Department of Medicine.  In this role she implements a wide range of programs to enhance the experience and advancement of faculty and trainees, with particular emphasis on under-represented minorities and women.

Education and Training

  • Fellow in General Internal Medicine, Medicine, Duke University, 1982 - 1983
  • Resident in Medicine, Medicine, Montefiore Medical Center, 1980 - 1982
  • Intern in Medicine, Medicine, Montefiore Medical Center, 1979 - 1980
  • M.D., Harvard University , 1979

Publications

Black, H. R., J. J. Bourgoignie, T. Pickering, L. Svetkey, M. C. Saddler, J. F. Setaro, and S. C. Textor. “Report of the Working Party Group for Patient Selection and Preparation..” Am J Hypertens 4, no. 12 Pt 2 (December 1991): 745S-746S. https://doi.org/10.1093/ajh/4.12.745s.

PMID
1777189
Full Text

Svetkey, L. P., R. Wilkinson, N. R. Dunnick, S. R. Smith, C. B. Dunham, M. Lambert, and P. E. Klotman. “Captopril renography in the diagnosis of renovascular disease..” Am J Hypertens 4, no. 12 Pt 2 (December 1991): 711S-715S. https://doi.org/10.1093/ajh/4.12.711s.

PMID
1777184
Full Text

Smith, S. R., L. P. Svetkey, and V. W. Dennis. “Racial differences in the incidence and progression of renal diseases..” Kidney Int 40, no. 5 (November 1991): 815–22. https://doi.org/10.1038/ki.1991.281.

PMID
1762285
Full Text

Debatin, J. F., C. E. Spritzer, T. M. Grist, C. Beam, L. P. Svetkey, G. E. Newman, and H. D. Sostman. “Imaging of the renal arteries: value of MR angiography..” Ajr Am J Roentgenol 157, no. 5 (November 1991): 981–90. https://doi.org/10.2214/ajr.157.5.1927823.

PMID
1927823
Full Text

Svetkey, L. P., S. Kadir, N. R. Dunnick, S. R. Smith, C. B. Dunham, M. Lambert, and P. E. Klotman. “Similar prevalence of renovascular hypertension in selected blacks and whites..” Hypertension 17, no. 5 (May 1991): 678–83. https://doi.org/10.1161/01.hyp.17.5.678.

PMID
2022411
Full Text

Roubidoux, M. A., N. R. Dunnick, P. E. Klotman, G. E. Newman, R. H. Cohan, S. Kadir, and L. P. Svetkey. “Renal vein renins: inability to predict response to revascularization in patients with hypertension..” Radiology 178, no. 3 (March 1991): 819–22. https://doi.org/10.1148/radiology.178.3.1994424.

PMID
1994424
Full Text

Black, H. R., J. J. Bourgoignie, T. Pickering, L. Svetkey, M. C. Saddler, J. F. Setaro, and S. C. Textor. “Report on the working party group for patient selection and preparation.” American Journal of Hypertension 4, no. 12 II SUPPL. (1991): 745S-746S.

Scholars@Duke

Weir, M. R., N. D. Vlachkis, V. DeQuattro, J. Douglas, L. P. Svetkey, S. Singh, S. C. Wiedl, C. F. Chen, D. L. Woodward, and E. Saunders. “Evaluation of the clinical pharmacology of nilvadipine in patients with mild to moderate essential hypertension..” J Clin Pharmacol 30, no. 5 (May 1990): 425–37.

PMID
2189903
Scholars@Duke

SVETKEY, L. P., C. B. DUNHAM, and P. E. KLOTMAN. “ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR VERSUS CONVENTIONAL THERAPY IN THE TREATMENT OF HYPERTENSION IN PATIENTS WITH RENAL-INSUFFICIENCY.” Clinical Research 38, no. 2 (April 1, 1990): A576–A576.

Scholars@Duke

Pages